United Guardian Inc
UG Nasdaq Perfumes, Cosmetics & Other Toilet Preparations Financials FY2016–FY2025
Last close · Oct 23, 2026
$6.67
1.9%What United Guardian Inc does
No business description yet.
- Legal name
- UNITED GUARDIAN INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 27, 2026
- Accession · CIK
- 0001171843-26-001973
0000101295
Revenue and margins
United Guardian Inc had $10.5M of revenue in fiscal 2025, down 13.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.9M in fiscal 2025, 18.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
United Guardian Inc returned $2.8M to shareholders in fiscal 2025, 145% of free cash flow. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably United Guardian Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $8.2M | $6.5M | $9.1M | $9.4M | $8.6M |
| Current ratio | 5.0x | 7.3x | 8.0x | 6.6x | 7.3x |
| Quick ratio | 4.4x | 6.0x | 7.2x | 5.9x | 6.4x |
| Total assets | $12.2M | $10.6M | $12.9M | $13.8M | $13.1M |
| Total liabilities | $2.4M | $1.4M | $1.5M | $1.9M | $1.9M |
| Shareholders' equity | $9.8M | $9.3M | $11.4M | $11.9M | $11.2M |
| Net debt (− = net cash) | — | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — | — | — | — | — | — | — | — |
| Current ratio rose | — | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ |
| Share count didn't rise | — | ✓ | ✓ | ✓ | ✓ | ✓ | — | — | — | — |
| Gross margin rose | — | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ |
| F-score | — / 3 | 7 / 8 | 8 / 8 | 5 / 8 | 6 / 8 | 7 / 8 | 4 / 7 | 4 / 7 | 6 / 7 | 3 / 7 |
| Accruals ratio | 2.0% | −1.1% | −4.7% | 2.3% | −2.4% | −5.4% | 0.4% | −4.8% | −1.6% | 1.0% |
| Altman Z'' | 23.89 | 18.93 | 18.19 | 17.49 | 17.11 | 14.82 | 17.63 | 17.48 | 16.10 | 15.38 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $10.8M | $13.0M | $13.4M | $0.0M | $11.0M | $13.9M | $12.7M | $10.9M | $12.2M | $10.5M |
| Gross profit | $5.9M | $7.7M | $8.1M | −$5.6M | $6.1M | $8.2M | $6.7M | $5.4M | $6.5M | $5.1M |
| Research and development | $0.7M | $0.6M | $0.4M | $0.4M | $0.5M | $0.5M | $0.5M | $0.5M | $0.5M | $0.5M |
| Operating income | $3.4M | $5.2M | $5.6M | $5.4M | $3.6M | $5.7M | $4.0M | $2.9M | $3.6M | $2.2M |
| Pretax income | $3.7M | $5.6M | $5.5M | $6.0M | $4.2M | $5.9M | $3.2M | $3.3M | $4.1M | $2.6M |
| Income tax | $1.1M | $1.7M | $1.1M | $1.3M | $0.9M | $1.2M | $0.7M | $0.7M | $0.9M | $0.5M |
| Net income | $2.6M | $3.8M | $4.4M | $4.8M | $3.3M | $4.7M | $2.6M | $2.6M | $3.3M | $2.1M |
| Diluted EPS | $0.56 | $0.84 | $0.95 | $1.04 | $0.72 | $1.01 | — | — | — | — |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | — | — | — | — |
| Cash flow | ||||||||||
| Cash from operations | $2.3M | $4.0M | $5.0M | $4.5M | $3.6M | $5.3M | $2.5M | $3.1M | $3.5M | $2.0M |
| Capital expenditure | $0.2M | $0.0M | $0.1M | $0.1M | $0.0M | $0.1M | $0.1M | $0.2M | $0.4M | $0.1M |
| Free cash flow | $2.1M | $4.0M | $4.9M | $4.4M | $3.6M | $5.2M | $2.5M | $3.0M | $3.0M | $1.9M |
| Depreciation and amortization | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M |
| Dividends paid | $3.4M | $6.5M | $4.8M | $5.0M | $3.6M | $5.2M | $3.1M | $0.5M | $2.8M | $2.8M |
| Dividends and buybacks | $3.4M | $6.5M | $4.8M | $5.0M | $3.6M | $5.2M | $3.1M | $0.5M | $2.8M | $2.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.4M | $8.4M | $8.2M | $7.9M | $8.2M | $8.2M | $6.5M | $9.1M | $9.4M | $8.6M |
| Current assets | $13.7M | $11.9M | $11.7M | $11.6M | $11.2M | $11.6M | $10.0M | $12.3M | $12.7M | $12.2M |
| Current liabilities | $1.0M | $1.4M | $1.4M | $1.3M | $1.4M | $2.3M | $1.4M | $1.5M | $1.9M | $1.7M |
| Inventory | $1.3M | $1.3M | $1.5M | $1.2M | $1.4M | $1.4M | $1.7M | $1.2M | $1.5M | $1.5M |
| Property and equipment, net | $1.1M | $0.9M | $0.8M | $0.8M | $0.7M | $0.7M | $0.6M | $0.6M | $1.0M | $0.9M |
| Total assets | $14.9M | $12.9M | $12.5M | $12.4M | $11.9M | $12.2M | $10.6M | $12.9M | $13.8M | $13.1M |
| Total liabilities | $1.0M | $1.5M | $1.6M | $1.7M | $1.6M | $2.4M | $1.4M | $1.5M | $1.9M | $1.9M |
| Shareholders' equity | $13.8M | $11.4M | $10.9M | $10.6M | $10.4M | $9.8M | $9.3M | $11.4M | $11.9M | $11.2M |
| Margins | ||||||||||
| Gross margin | 54.7% | 59.1% | 60.3% | −41,498.5% | 55.7% | 58.7% | 52.8% | 49.7% | 53.0% | 48.8% |
| Operating margin | 31.5% | 40.4% | 41.5% | 39,676.5% | 33.1% | 40.7% | 31.8% | 26.3% | 29.9% | 21.3% |
| EBITDA margin | 33.2% | 41.9% | 42.9% | 40,969.1% | 34.6% | 41.7% | 32.9% | 27.3% | 30.7% | 22.3% |
| Net margin | 24.0% | 29.6% | 32.4% | 35,012.5% | 30.1% | 33.4% | 20.2% | 23.7% | 26.7% | 20.0% |
| FCF margin | 19.7% | 30.5% | 36.3% | 32,075.7% | 32.3% | 37.3% | 19.3% | 27.4% | 24.9% | 18.1% |
| Returns | ||||||||||
| Return on capital employed | 24.5% | 45.8% | 49.9% | 49.0% | 34.6% | 57.2% | 43.6% | 25.1% | 30.7% | 19.6% |
| Return on equity | 18.7% | 30.5% | 39.0% | 44.2% | 31.5% | 46.2% | 26.9% | 25.0% | 27.9% | 18.2% |
| Return on assets | 17.4% | 27.7% | 34.3% | 38.2% | 27.2% | 38.6% | 22.5% | 21.9% | 24.3% | 15.7% |
| Return on tangible equity | 18.7% | 33.7% | 39.8% | 44.8% | 31.9% | 47.4% | 27.7% | 22.7% | 27.4% | 18.7% |
| Growth | ||||||||||
| Revenue growth | — | 20.3% | 3.7% | −99.9% | 80,680.1% | 26.8% | −8.8% | −14.3% | 11.9% | −13.4% |
| Net income growth | — | 48.9% | 13.2% | 9.4% | −30.6% | 41.0% | −44.8% | 0.5% | 25.9% | −35.2% |
| EPS growth | — | 50.0% | 13.1% | 9.5% | −30.8% | 40.3% | — | — | — | — |
| FCF growth | — | 86.2% | 23.3% | −10.5% | −18.6% | 46.4% | −52.9% | 21.6% | 1.8% | −37.1% |
| Share count change | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Financial health | ||||||||||
| Current ratio | 13.1x | 8.3x | 8.6x | 8.6x | 8.0x | 5.0x | 7.3x | 8.0x | 6.6x | 7.3x |
| Quick ratio | 11.9x | 7.4x | 7.5x | 7.7x | 7.0x | 4.4x | 6.0x | 7.2x | 5.9x | 6.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.5% | 0.3% | 0.6% | 836.8% | 0.4% | 0.8% | 0.6% | 1.5% | 3.6% | 0.6% |
| Payouts / FCF | 161.8% | 164.6% | 98.8% | 115.8% | 100.9% | 99.9% | 127.5% | 15.4% | 90.9% | 145.0% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 7.0 | 8.0 | 5.0 | 6.0 | 7.0 | 4.0 | 4.0 | 6.0 | 3.0 |
| Altman Z'' | 23.9 | 18.9 | 18.2 | 17.5 | 17.1 | 14.8 | 17.6 | 17.5 | 16.1 | 15.4 |
| Accruals ratio | 2.0% | −1.1% | −4.7% | 2.3% | −2.4% | −5.4% | 0.4% | −4.8% | −1.6% | 1.0% |
Source: SEC EDGAR XBRL filings (CIK 0000101295). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
